128 related articles for article (PubMed ID: 13742324)
1. Micellar size of mixed lysolecithin-lecithin sols.
ROBINSON N
J Pharm Pharmacol; 1961 Jan; 13():53-7. PubMed ID: 13742324
[No Abstract] [Full Text] [Related]
2. The physical properties of lysolecithin and its sols. II. Refractive indices and densities of sols; micelle formation.
ROBINSON N; SAUNDERS L
J Pharm Pharmacol; 1958 Dec; 10(12):755-61. PubMed ID: 13611642
[No Abstract] [Full Text] [Related]
3. Some properties of mixed sols of lecithin and lysolecithin.
SAUNDERS L
J Pharm Pharmacol; 1957 Dec; 9(12):834-9; discussion 839-40. PubMed ID: 13492170
[No Abstract] [Full Text] [Related]
4. The physical properties of lysolecithin and its sols. IV. Solubilisation.
ROBINSON N; SAUNDERS L
J Pharm Pharmacol; 1959 Jun; 11(6):346-51. PubMed ID: 13655192
[No Abstract] [Full Text] [Related]
5. Intestinal cholesterol uptake: comparison between mixed micelles containing lecithin or lysolecithin.
Reynier MO; Lafont H; Crotte C; Sauve P; Gerolami A
Lipids; 1985 Mar; 20(3):145-50. PubMed ID: 3990523
[TBL] [Abstract][Full Text] [Related]
6. The physical properties of lysolecithin and its sols. III. Viscosity.
ROBINSON N; SAUNDERS L
J Pharm Pharmacol; 1959 May; 11(5):304-13. PubMed ID: 13655186
[No Abstract] [Full Text] [Related]
7. The physical properties of lysolecithin and its sols. I. Solubilities, surface and interfacial tensions.
ROBINSON N; SAUNDERS L
J Pharm Pharmacol; 1958 Jun; 10(6):384-91. PubMed ID: 13550080
[No Abstract] [Full Text] [Related]
8. Metabolism of lysolecithin and lecithin in a yeast supernatant.
KOKKE R; HOOGHWINKEL GJ; BOOIJ HL; van den BOSCH ; ZELLES L; MULDER E; van DEENEN L
Biochim Biophys Acta; 1963 Jun; 70():351-3. PubMed ID: 14034315
[No Abstract] [Full Text] [Related]
9. Conversion of lecithin to lysolecithin as a source of fatty acids in incubated plasma or serum.
VOGEL WC; ZIEVE L
Proc Soc Exp Biol Med; 1962 Dec; 111():538-40. PubMed ID: 13997657
[No Abstract] [Full Text] [Related]
10. Surface interaction of lecithin and lysolecithin.
ROBINSON N
J Pharm Pharmacol; 1960 Oct; 12():609-16. PubMed ID: 13742325
[No Abstract] [Full Text] [Related]
11. Detection of lysolecithin in a sample of egg lecithin.
SAUNDERS L; PERRIN J
J Pharm Pharmacol; 1960 Dec; 12(Suppl)():257-9. PubMed ID: 13746799
[No Abstract] [Full Text] [Related]
12. [Studies on the isolation of egg lecithin and lysolecithin].
WAKUI K; KAWACHI S
Yakugaku Zasshi; 1961 Oct; 81():1401-4. PubMed ID: 14004497
[No Abstract] [Full Text] [Related]
13. Inhibitory action of serum lecithin on the hemolytic activity of serum lysolecithin in vitro.
GJONE E
Scand J Clin Lab Invest; 1961; 13():369-73. PubMed ID: 13899057
[No Abstract] [Full Text] [Related]
14. Measurement of serum lecithin, lysolecithin, and sphingomyelin by a simplified chromatographic technique.
VOGEL WC; ZIEVE L; CARLETON RO
J Lab Clin Med; 1962 Feb; 59():335-44. PubMed ID: 13926441
[No Abstract] [Full Text] [Related]
15. CONVERSION OF LIPOPROTEIN-BOUND LECITHIN TO LYSOLECITHIN INDUCED BY SNAKE-VENOM PHOSPHOLIPASE A.
KLIBANSKY C; HENIG S; SHILOAH J; DEVRIES A
Biochim Biophys Acta; 1963 Oct; 70():591-3. PubMed ID: 14085944
[No Abstract] [Full Text] [Related]
16. Clearing action of lysolecithin.
SAUNDERS L; THOMAS IL; ROBINSON N
Nature; 1958 Mar; 181(4611):782. PubMed ID: 13517312
[No Abstract] [Full Text] [Related]
17. Morphology of lipid micelles containing lysolecithin.
Inoue K; Suzuki K; Nojima S
J Biochem; 1977 Apr; 81(4):1097-106. PubMed ID: 18447
[TBL] [Abstract][Full Text] [Related]
18. Clearing action of lysolecithin on brain homogenates.
WEBSTER GR
Nature; 1957 Sep; 180(4587):660-1. PubMed ID: 13477253
[No Abstract] [Full Text] [Related]
19. [Studies on hemolytic activity of lysolecithin].
JUNG F
Cesk Fysiol; 1959 Apr; 8(3):208. PubMed ID: 13671547
[No Abstract] [Full Text] [Related]
20. [Hemolytic activity of lysolecithin in splenomegaly, before and after splenic reduction].
FAVA PL; ERIDANI S; CASAGRANDE A
Haematologica; 1955; 39(10):683-702. PubMed ID: 13306003
[No Abstract] [Full Text] [Related]
[Next] [New Search]
